Estrela Neto
Has grant
Associate Researcher
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Open
Modulação da inflamação associada à obesidade por peptídeos bioativos derivados da dieta.
Open Date: 2026-02-23
Close Date: 2027-08-22
Grant: Open
Engenharia avançada do nicho inervado pré-metastático humano: o impacto das vesículas extracelulares de cancro da próstata na neurotização patológica da metástase óssea
Open Date: 2025-01-01
Close Date: 2027-12-31
Grant: Open
Deciphering the impact of prostate cancer exosomes in bone sensory innervation profile to shape the pre-metastatic niche formation
Open Date: 2025-01-01
Close Date: 2030-12-31
Grant: Close
Organ-on-a-chip systems are the animal’s best friends
Open Date: 2022-03-01
Close Date: 2023-08-01
Grant: Close
O STRESS E A METÁSTASE ÓSSEA NO CANCRO DA MAMA: investigar o Yin-Yang da sinalização simpática adrenérgica
Open Date: 2022-01-01
Close Date: 2023-10-31
Articles (5)
Year:
2025
Acute myeloid leukaemia (AML) management remains a significant challenge in oncology due to its low survival rates and high post-treatment relapse rates, mainly attributed to treatment-resistant leukaemic stem cells (LSCs) residing in bone marrow (BM) niches. This review offers an in-depth analysis of AML progression, highlighting the pivotal role of extracellular vesicles (EVs) in the dynamic remodelling of BM niche intercellular communication. We explore recent advancements elucidating the mechanisms through which EVs facilitate complex crosstalk, effectively promoting AML hallmarks and drug resistance. Adopting a temporal view, we chart the evolving landscape of EV-mediated interactions within the AML niche, underscoring the transformative potential of these insights for therapeutic intervention. Furthermore, the review discusses the emerging understanding of endothelial cell subsets’ impact across BM niches in shaping AML disease progression, adding another layer of complexity to the disease progression and treatment resistance. We highlight the potential of cutting-edge methodologies, such as organ-on-chip (OoC) and single-EV analysis technologies, to provide unprecedented insights into AML–niche interactions in a human setting. Leveraging accumulated insights into AML EV signalling to reconfigure BM niches and pioneer novel approaches to decipher the EV signalling networks that fuel AML within the human context could revolutionise the development of niche-targeted therapy for leukaemia eradication.
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Collaborators (8)
Catarina Leite Pereira
Assistant Researcher
i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto
Paula Parreira
Associate Researcher
i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto
Meriem Lamghari
Instituto Universitário de Ciências da Saúde
Daniela Vasconcelos
Junior Researcher - CEEC
Instituto de Investigação e Inovação em Saúde da Universidade do Porto
Meriem Moubarrad
i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto
Hugo R. Caires
University of Porto
Delfim Duarte
Group Leader
i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto
Paulo Freitas
Universidade Autónoma de Lisboa
Make your next move.
Prepare your application
Review drafts before you send them.